REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -99.9% | 8,308 | +274.1% | 0.00% | – |
| Q3 2022 | $1,000 | -90.0% | 2,221 | -80.8% | 0.00% | – |
| Q2 2022 | $10,000 | -56.5% | 11,592 | +25.5% | 0.00% | – |
| Q1 2022 | $23,000 | -81.5% | 9,233 | -80.9% | 0.00% | – |
| Q4 2021 | $124,000 | -35.8% | 48,351 | +78.2% | 0.00% | – |
| Q3 2021 | $193,000 | +1.6% | 27,132 | -2.2% | 0.00% | – |
| Q2 2021 | $190,000 | – | 27,732 | +127.1% | 0.00% | – |
| Q4 2020 | $0 | – | 12,213 | -20.3% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 15,317 | -54.3% | 0.00% | – |
| Q2 2020 | $224,000 | +64.7% | 33,545 | +11.7% | 0.00% | – |
| Q1 2020 | $136,000 | -3.5% | 30,027 | +28.8% | 0.00% | – |
| Q4 2019 | $141,000 | +14000.0% | 23,320 | +11618.6% | 0.00% | – |
| Q3 2018 | $1,000 | – | 199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 444,301 | $2,284,000 | 1.33% |
| 683 Capital Management, LLC | 999,232 | $5,136,000 | 0.43% |
| DAFNA Capital Management LLC | 35,000 | $180,000 | 0.10% |
| MENORA MIVTACHIM HOLDINGS LTD. | 421,000 | $2,164,000 | 0.08% |
| Migdal Insurance & Financial Holdings Ltd. | 397,324 | $2,042,000 | 0.05% |
| Claret Asset Management Corp | 42,522 | $219,000 | 0.05% |
| Orbimed Advisors | 564,900 | $2,904,000 | 0.04% |
| Altshuler Shaham Ltd | 169,446 | $251,000 | 0.04% |
| Virtu Financial LLC | 60,787 | $312,000 | 0.02% |
| MEITAV INVESTMENT HOUSE LTD | 48,000 | $244,000 | 0.01% |